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Empirical research on informed consent has shown that study participants often do not fully
understand consent information. This study assessed participant understanding of three mock
consent approaches describing an HIV-prevention clinical trial in Lilongwe, Malawi prior to trial
implementation. Pregnant women (n = 297) were systematically selected from antenatal-care
waiting lines and sequentially allocated to receive an enhanced standard consent form (group 1), a
context-specific consent form (group 2), or context-specific counseling cards (group 3).
Understanding of research concepts and study procedures was assessed immediately
postintervention and at 1-week follow-up. At postintervention, participants in groups 2 and 3
understood more about research concepts and study procedures compared with group 1. Group 3
participants also understood more about study procedures compared with group 2. At follow-up,
participants in groups 2 and 3 continued to understand more about research concepts and study
procedures. Context-specific approaches improved understanding of consent information in this
study.
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Introduction
Obtaining informed consent from study participants is mandatory in clinical research.
Respect for persons, the underlying ethical principle of informed consent, cannot be
safeguarded without adequate disclosure of information, sufficient participant understanding
of the information, and a voluntary agreement to participate in research [1]. According to
U.S. and international ethical guidelines, participant understanding of consent information is
a condition that must be sufficiently met before potential study participants can give their
informed consent [1–4]. Yet empirical research on informed consent has shown that study
participants often do not understand the information provided to them during the consent
process, both in resource-rich and resource-limited countries [5–12]. Although barriers to
administering informed consent in developing countries have been noted in the literature
[13–16], many researchers believe that limited participant understanding of consent
information due to differences in cultural backgrounds, health belief systems, and languages
as well as barriers due to illiteracy can be overcome [17–19]. Improvements in
understanding have been demonstrated in these settings [20–23].
Many studies have evaluated alternative methods of improving participant understanding of
consent information or have used alternative methods for informing potential study
participants about a research study. Despite these efforts, only some methods have improved
participant understanding of consent information [24–26]. With a few exceptions [19, 20],
most alternative approaches have focused on simplifying text or using new methods of
disclosing information rather than modifying the text to make it meaningful to participants.
However, readability formulas are insufficient for ensuring that the information makes sense
to potential study participants [27] or is at a low reading level when the information will be
translated into another language [28]. In a review of informed consent interventions in the
U.S., the authors suggested that it might be more effective to focus on the informational
process, such as the words or terms used to explain research concepts, rather than on the
method of presenting the information [29, 30]. Similarly, for U.S.-regulated international
research conducted in developing countries, the National Bioethics Advisory Commission
[17] recommends that researchers focus on disclosing consent information using culturally
appropriate and innovative means, which may include both the informational process and
method of delivery.
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Our decision to conduct research on developing and evaluating a culturally-appropriate
informed consent process emerged in response to formative data we collected to inform
protocol development for the Breastfeeding, Antiretrovirals, and Nutrition (BAN) Study, a
clinical trial in Lilongwe, Malawi, on the safety and efficacy of antiretroviral and nutrition
interventions to reduce mother-to-child transmission of HIV during breastfeeding [31].
Objectives of the BAN study included evaluating the benefit of nutritional supplementation
given to mothers during breastfeeding, the benefit and safety of antiretroviral medications
given either to infants or to their mothers to prevent HIV transmission during breastfeeding,
and the feasibility of exclusive breastfeeding, followed by early, rapid breastfeeding
cessation. The study design was a 2-by-3 factorial design where mothers received or did not
receive a daily nutritional supplement, and mothers, infants, or neither were given
antiretrovirals for a 24- to 28-week breastfeeding period. Healthy breastfeeding mothers
with a CD4 count >200 cells/μl and hemoglobin ≥7 g/dl and their HIV-negative newborns
were eligible to enroll.
The formative research was conducted in June and July 2002 with HIV-positive mothers and
other members of the community, and the results suggested that the community had a
limited understanding of medical research [32]. Respondents believed that study participants
would be assigned to a study arm based on their individual health needs, that they would
receive a therapeutic benefit from their participation, and that all medicines provided would
already have been tested and known to be safe and efficacious. These data demonstrated that
further investigation of participant understanding of research was needed to increase the
effectiveness of the informed consent process for the clinical trial. For that reason, in May
2003, we conducted additional formative research with mothers infected with HIV and with
other members of the community specifically on how to better explain consent information
to potential study participants [33]. Findings from both formative studies were used to
modify the informed consent process specifically for the Malawian context.
Here we describe the evaluation of three consent approaches, including two context-specific
approaches, to determine which approach obtained the highest level of participant
understanding of research concepts and study procedures related to the BAN study. The
evaluation was an independent substudy of the BAN study and was conducted several
months before recruitment for the clinical trial began.
The research was approved by the National Health Science Research Committee in Malawi
and the institutional review boards at the Centers for Disease Control and Prevention and
The University of North Carolina at Chapel Hill in the U.S.
Methods
Study Population
Pregnant women with unknown HIV status were recruited from two antenatal clinics that
later served as recruitment sites for the BAN study. We excluded women who were known
to be infected with HIV because of concern that they might believe they were enrolling in
the BAN study rather than participating only in a mock consent evaluation. Another reason
for enrolling women of unknown HIV status was that we did not want to inform pregnant
women infected with HIV about an upcoming clinical trial for which they would not be
eligible because of the timing of their delivery. Because the participants in our study were of
unknown HIV status, they would not have considered themselves eligible for the BAN
clinical trial. Further, to reduce the possibility that participants would believe they were
enrolling in the BAN study, potential participants were informed during screening and twice
during the informed consent process that they were not being asked to take part in the BAN
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study but rather they would hear information and be asked questions about the BAN study in
order to find out the best way to explain information about the study to future participants.
Data Collection
Participants were selected from the waiting lines at the antenatal clinics from September to
December 2003 using a systematic sampling strategy. First, participants were informed in a
group about the study as they waited for the clinic to open. All women typically arrived for
care early in the morning; women who were HIV-positive received care separately. Next,
potential participants were selected by asking every “nth” woman in line, based on the total
number of women in line that day, if she would be interested in participating in the study. If
yes, she would meet with study staff to learn more about the study. After giving written
informed consent, participants were sequentially allocated to one of three mock consent
interventions. With this allocation method, participants were placed into group 1 until the
targeted sample size was achieved, and then in groups 2 and 3 following the same approach.
This study design was necessary to reduce intervention contamination that might have
occurred because the same six nurses delivered the consent information for each group, and
groups 2 and 3 included context-specific information. All mock consent interventions were
administered individually to the participants on the same day they were recruited from the
antenatal care line.
All participants received four bars of household soap and a ½ kg bag of iodized salt for
participating in the mock informed consent process and the post-intervention interview; no
travel costs were incurred by participants for the first visit as they were already at the clinic
for antenatal care. All participants were provided with 200 Malawian Kwacha
(approximately $2.00) for transportation costs to the health facility for the follow-up
interview.
Participants’ understanding of research concepts and study procedures was assessed
immediately after the consent intervention was delivered and again 1 week later. To assess
participant understanding of research concepts, we modified an existing validated scale [34]
and field-tested it extensively prior to use to ensure that the questions and categories were
culturally appropriate. The 20-item scale measured participants’ understanding of the eight
basic elements of informed consent as outlined by U.S. regulations [35]. After field-testing,
the original response categories of “agree,” “disagree,” and “unsure” were changed to
“true,” “not true,” and “unsure”. Following the same scoring procedures as in the original
scale, a total of 100 points could be obtained; correct answers were assigned a score of 100,
incorrect answers were assigned a score of 0, and the response category “unsure” was
assigned a score of 50.
Questions that assessed participants’ understanding of study procedures were informed by
the basic procedures described in the protocol and by our formative findings. Twenty-four
open- and closed-ended questions were asked, covering participants’ understanding of five
domains: eligibility criteria, ARV intervention, nutrition intervention, blood draws, and
breastfeeding protocol. Scores indicate the percentage of correct answers. Open-ended
questions were coded either correct or incorrect.
For both measures, a higher score indicates better understanding. The questionnaire was
field-tested with a total of 24 HIV-positive women and women of unknown HIV status.
Appropriate modifications were made to improve clarity and appropriateness.
We also collected data on the time needed to deliver each consent approach; nurses’
perceptions of participants’ attentiveness at the beginning, middle, and end of the mock
consent session rated on a 4 point scale (very attentive, moderately attentive, slightly
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attentive, and not attentive at all); participants’ understanding of consent information 1-week
after the intervention; and participants’ and nurses’ perceptions of the different approaches.
Nurses and other field staff provided advice on what behaviors would be representative of
inattentiveness among Malawian women in a clinic setting. Behaviors included frequent
yawning, falling asleep, staring out the window, looking around the room, or nurses having
to repeat a question because the participant did not appear to be listening.
Two areas of participants’ perceptions that were of specific interest were their perceptions of
the amount of time needed to deliver each approach and the amount of information
presented in each approach. To measure participants’ perceptions of time, they were asked
whether the time taken to present and discuss the information was “too long,” “just right,” or
“too little.” Similarly, for the amount of information presented, participants were asked
whether the amount was “too much,” “just right,” or “too little.”
Interventions
The three intervention groups were as follows–
Group 1: For group 1, an enhanced standard informed consent form was used (Table 1).
U.S. investigators wrote the form based on a U.S. medical school consent form template
that used a question-and-answer format; section headers were based on the eight
required elements of informed consent as well as additional elements as appropriate.
This form was IRB-approved for the clinical trial. In comparison with the average
Flesh-Kincaid Grade Level score of 10.6 reported in a study of 114 medical school
consent form templates [36], the enhanced standard form was written with much
simpler language (English), rating a score of 7.4. Nurses followed the standard practice
for administering the consent process at the study site by summarizing each section
after it was read aloud to the participant and asking unstructured questions to gauge
participants’ understanding of the section. Nurses did not proceed until they believed
the participant understood the information from each section. The Chichewa version
was 10 pages in length (9 in English) and contained a total of 3,386 words.
Group 2: For group 2, a context-specific consent form was used that was informed by
our formative research findings [32, 33], theory [37, 38], a descriptive framework for
developing culturally appropriate interventions [39], and recommendations in the
literature [17, 40–42]. “Context-specific” means that consent information was described
using local words and sentence structure, meanings, and analogies as discovered
through the formative research, that formative data informed areas in which additional
explanation was needed because of limited understanding among the study population,
that recommendations from the literature for improving and ensuring participant
understanding of consent information were followed, and that local health professionals
contributed to the design of the consent information. As with group 1, nurses asked
participants questions after reading each section of the consent form to gauge the
participant’s understanding and did not proceed until they believed the participant
understood the section; information was not summarized after each section. Structured
questions were used to assess understanding of the previous section as a way to increase
the fidelity of the standard method at the site of asking questions throughout the
delivery of the consent information and to ensure that information identified as
problematic in the formative research was understood. The Chichewa version was 13
pages in length (12 in English) and contained a total of 6,317 words.
Group 3: For group 3, counseling cards were used and they combined the context-
specific informational approach of group 2 with culturally appropriate drawings of each
stage of the protocol (Fig. 1). Counseling cards are used in Malawi for providing family
planning education in the clinics; thus, it is a familiar method for delivering
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information. The context-specific text was distributed over 46 pages in a flip chart, each
with a drawing on the reverse side. The addition of drawings was the only difference
between groups 2 and 3.
Information covering the eight basic elements of informed consent as outlined in U.S.
federal regulations [35] was presented to each group. Because of the use of context-specific
information, more information was presented to participants in groups 2 and 3 compared to
group 1.
Statistical Analyses
We hypothesized that there would be no differences in the level of understanding of research
concepts or study procedures by participants in all three groups directly after the consent
information was delivered. One-way analysis of variance (ANOVA) was used to compare
participant demographics, participant understanding, and time to deliver consent information
among the groups. Significant ANOVA tests were followed by a Tukey–Kramer multiple
comparisons procedure to determine which groups were different. For the categorical data,
multiple pair-wise comparisons of binary data were conducted using the global permutation
distribution to produce the Fisher exact test for two-sample comparisons [43]. All P values
for group comparisons listed in the tables have been adjusted for multiple comparisons.
Student t-tests were used to determine the comparability of postintervention participants
with the participants who did not return for follow-up. All statistical tests were conducted




A total of 297 participants were enrolled in the study; 96 participants were assigned to group
1, 101 to group 2, and 100 to group 3. Number of years in school averaged 6.7 for group 1,
6.8 for group 2, and 7.5 for group 3. Participant age averaged 23.2 years for group 1, 23.7
years for group 2, and 23.3 years for group 3. There were no significant differences among
participants in the three groups with respect to education (F2,293 = 1.48, P = 0.23) or age
(F2,288 = 0.45, P = 0.64). About 10% of women who were invited to join the study declined
to participate. The discontinuation rate during the delivery of the intervention and
postintervention questionnaire was less than 2%. These rates did not differ by group.
Participant Understanding Post-Intervention
Understanding of research concepts differed significantly among the groups (Table 2).
Participants in groups 2 and 3 understood significantly more information about research
concepts postintervention compared with participants in group 1. Although the mean score
for understanding of research concepts among participants in group 3 was higher than the
mean score in group 2, the difference was not significant. Similarly, understanding of study
procedures differed significantly among the groups. Participants in groups 2 and 3
understood significantly more information about study procedures postintervention
compared with participants in group 1. Additionally, participants in group 3 understood
significantly more information compared with participants in group 2.
Supplemental Findings
Time and Amount of Information—Time needed to deliver the consent information
averaged 59 min for group 1, 72 min for group 2, and 73 min for group 3. Differences in
time among the three groups were significant (F2,294 = 75.41, P <0.001) as were differences
between groups 1 and 2 (P <0.001), and groups 1 and 3 (P <0.001). Although more time
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was needed to deliver the consent information in groups 2 and 3 compared with group 1,
participants’ perceptions of whether the amount of time needed to deliver the information
was “too long” did not vary significantly among the groups. Moreover, there were no
significant differences between groups 1 and 3 in participants’ perceptions that the amount
of consent information provided was “too much,” although more information was presented
in group 3. Conversely, while the same amount of information was presented in groups 2
and 3, significantly more participants in group 2 perceived the amount of information to be
“too much” compared to those in group 1 (Table 3).
Nurses reported that while a similar percentage of participants in all three groups were
perceived to be “very attentive” at the beginning of the consent session, by the end of the
session, significantly more participants continued to be “very attentive” in groups 2 and 3
compared to those in group 1. There were no significant differences between groups 2 and 3
in nurses’ perceptions of participants’ attentiveness at the end of the consent session (Table
3).
Participant Understanding at the 1 Week Follow-Up Assessment—Fifty-three
participants (55%) from group 1 returned 1 week after the intervention for the follow-up
interview, 63 (62%) returned from group 2, and 67 (67%) returned from group 3. There
were no significant differences among participants in the three follow-up groups in
education (F2,180 = 0.59, P = 0.56) or age (F2,177 = 0.76, P = 0.47). Within each group there
were no significant differences in education and age between participants who returned for
the follow-up interview and those who did not.
Scores from the follow-up assessment revealed similar patterns to that of the
postintervention assessment scores, with understanding of research concepts and study
procedures differing significantly among the groups (Table 2). One week after the
intervention, participants in groups 2 and 3 understood significantly more information about
both research concepts and study procedures compared to participants in group 1.
Participants’ understanding of research concepts was not significantly different between
groups 2 and 3, and, unlike the postintervention assessment, participants’ understanding of
study procedures was not significantly different between groups 2 and 3.
Preferences of Nurses—All six nurses preferred the counseling cards over the context-
specific and enhanced standard consent forms. One nurse said, “Because the counseling
cards had pictures to illustrate the information, it was easier for the clients to understand
and to keep them alert.” Another said, “Counseling cards are suitable for Malawian women.
Most Malawian women are illiterate, so the pictures really assisted them.” In fact, nurses
said the counseling cards would be best at keeping them motivated to ensure participants’
understanding throughout the clinical trial. As described by one nurse: “Because after asking
questions throughout the consent process, clients are responding well, so as a nurse you are
motivated.”
Discussion
These data are relevant to the literature on participant understanding of informed consent
given that these data are not time-sensitive, and participant understanding of consent
information continues to be a concern. The results demonstrated that of the three methods
evaluated, the counseling cards were the most effective intervention for improving
participant understanding of the consent information. Participants who received the
counseling cards intervention understood more information about research concepts and
study procedures after the intervention than participants who received the enhanced standard
consent form intervention and they understood more information about study procedures
Corneli et al. Page 7













than participants who received the context-specific consent form intervention. Moreover, at
the follow-up 1 week later, participants who received the counseling cards intervention
continued to understand more information about research concepts and study procedures
than participants who received the enhanced standard consent form intervention.
Data on participants’ and nurses’ perceptions also support the use of both the counseling
cards and the context-specific consent form. Participants’ perceptions of the amount of time
needed to present the consent information did not differ among the groups, and therefore the
additional time needed to present the context-specific consent form or the counseling cards
might not be problematic from the participant’s perspective. In fact, the nurses reported that
participants remained significantly more attentive throughout the delivery of the two
context-specific interventions compared with that of the enhanced standard consent form
intervention. These findings suggest that the use of a context-specific approach may increase
participant interest in the consent process.
Further, the addition of drawings may have increased participant engagement with the
information given that significant differences were found between groups 1 and 2 in
participants’ perception of whether the amount of information presented was “too much” but
not between groups 1 and 3, even though the same amount of information was presented in
groups 2 and 3. Indeed, two functions of drawings are to increase participant attention to and
engagement with information presented [44]. All nurses indicated that they preferred the
counseling cards over the other two interventions.
Our findings also support previous research demonstrating that the use of locally-relevant
analogies [45] and the inclusion of drawings with text simplification [46] contributed to
participants’ continued understanding of concepts over time compared with participants who
received information that did not include analogies or drawings with text simplification. In
our study, the overall mean follow-up scores for participants who received the context-
specific consent form intervention or the counseling cards intervention were at least 10
percentage points higher than the overall mean follow-up score for participants who
received the enhanced standard consent form intervention.
The time needed to deliver the context-specific approaches is comparable to phase three
clinical trials conducted in developing countries where consent for enrollment may take 1 h
or more, depending on the participant’s level of understanding. Yet, a lengthy informed
consent process often leads to long clinic visits for participants and may not be needed for
comprehension. Research is needed on how to streamline the informed consent process
without compromising participant understanding. In a recent study, authors reported that
comprehension scores were similar across participants who received either a standard or
concise consent form, suggesting that providing less information may not hinder
comprehension [47].
Our study enrolled a surrogate population and did not conduct the study with participants in
an actual clinical trial. The use of surrogate populations is not uncommon in empirical
research on informed consent [29, 48], although some researchers believe that, when
appropriate, research on informed consent should be conducted in a realistic context [49].
Because in this study we were testing two experimental informed consent approaches for a
complicated 6-treatment-condition clinical trial with three interventions among a vulnerable
population, we elected to enroll a surrogate population to evaluate the effectiveness of the
consent approaches in improving participant understanding before use in a real setting.
Furthermore, the study population was not infected with HIV, and therefore the consent
information may not have been salient to them. Although it is unknown whether HIV status
is related to understanding of consent information, participants in our study might not have
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been as attentive as women infected with HIV because they did not need to consider
participation in the BAN study. Conversely, women with HIV might have paid less attention
to the information because of anxiety. Because we enrolled a surrogate population of women
with unknown HIV status, we chose to measure only the informational aspects of the
consent information rather than hypothetical attitudinal factors such as perception of risk or
decision making which might differ between women of unknown HIV status and women
infected with HIV.
In addition, as is the case with most multicomponent interventions, our design did not permit
us to identify the specific contributions of each intervention component to improved
participant understanding of consent information. While we know that both context-specific
approaches worked better than the enhanced standard form, we cannot attribute specific
effects, for example, to the use of drawings versus no drawings or to structured versus
unstructured questions.
It is also possible that nurses became more proficient at presenting the consent interventions
with each successive intervention because the interventions were assigned sequentially. On
the other hand, nurses may have become fatigued over time. However, one indicator of
proficiency—the time to deliver the consent information—did not provide any evidence that
the nurses’ proficiency changed as the amount of time needed to deliver the consent
information did not decrease over time within each group. Lastly, we chose to limit our
research on informed consent to the evaluation of comprehension. Other social contextual
factors that may influence informed consent—such as limited access to quality health care—
were not explored in this study.
Despite these limitations, we believe our study has important implications for informed
consent design. Before these research findings can be translated into practice, however,
several issues should be considered. First, although the results are not generalizable beyond
the BAN study and consent approaches used in this evaluation, the methods we used in
conducting the formative research and developing and implementing the context-specific
approaches (see [33] and described above) could be replicated not only for other U.S.-
regulated international clinical trials but also for clinical trials conducted in the U.S.
Previous research has demonstrated the effectiveness of interventions when they were
informed of theory and by findings from formative research, were culturally appropriate, or
used drawings with text simplifications [46, 50–54]. Given that our context-specific
approaches incorporated these factors, we believe these approaches might also be effective
in improving participant understanding of consent information in other settings.
Second, our findings suggest that if resources do not permit the development of counseling
cards for the informed consent process, the use of a context-specific consent form as
described here can improve participant understanding of consent information. At the same
time, however, we cannot ignore the fact that approximately half of the participants who
received the context-specific consent form intervention perceived the amount of information
to be “too much.” Additional research should be conducted to find a balance between
providing context-specific information to enhance understanding and maintaining
participant satisfaction.
Third, although our results demonstrated that both context-specific approaches improved
understanding compared with the enhanced standard form, the mean scores were lower than
we would have preferred, and therefore additional improvements should be made to these
approaches. Previous research has shown that multiple meetings [23] can improve
participant understanding of consent information. Further research should be conducted to
determine if combining this method with a context-specific approach would enhance
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participant understanding of consent information given the amount of additional information
that may accompany a context-specific approach.
Fourth, our findings support reports [29, 30] suggesting that approaches for improving
participant understanding of consent information may need to focus more on the
informational process than on the method of delivery. At the same time, however, our
findings also demonstrated that use of the counseling card intervention enhanced
participants’ understanding and interest, which suggests the method of presenting the
information is also important.
Conclusion
If participants do not understand the information provided during the consent process, their
consent is not meaningful. Our results demonstrate that going beyond the use of a generic
consent form that is simply stated and structured and using a context-specific approach
instead can lead to improvements in participant understanding.
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Table 1
Excerpt from the enhanced standard consent form that provides an overview of the BAN study
What is the study about?
Mothers who have HIV can pass it to their babies. This can happen during pregnancy, around the time of delivery, and after the baby is born
through breastfeeding. This study is looking for ways to prevent HIV transmission during breastfeeding. It is also looking for ways to keep
HIV-infected mothers and their babies healthy.
There are medicines to help prevent HIV transmission from mothers to babies during pregnancy and around the time of delivery. There are also
medicines to treat people infected with HIV when they become very sick. These medicines are called anti-retroviral drugs.
In this study we will be comparing different anti-retroviral drugs to prevent HIV transmission from mothers to babies during breastfeeding.
HIV-infected mothers who are not very sick will be put in one of three groups. Some mothers will take a combination of drugs while they are
breastfeeding. Other mothers will be given a drug for their babies to take every day while they are breastfeeding. The third group of mothers
will not be given drugs to take while they are breastfeeding.
This study will also give half of the mothers a special food supplement. It will be eaten daily while breastfeeding. The purpose of this part of the
study is to see if the special food supplement helps to keep mothers who have HIV healthy while they are breastfeeding.
Mothers will be asked to stop breastfeeding when their babies are 6 months old in order to prevent HIV transmission. Once mothers stop
breastfeeding, they will be given a special weaning food to feed to their infants. The drugs and mother’s special food supplement will be
stopped when the baby is weaned at 6 months.
The findings from this study will answer three questions that will help the Government of Malawi to provide better health care to HIV-infected
mothers and their babies:
1 Can anti-retroviral drugs given to mothers or to babies help safely prevent the babies from getting HIV during breastfeeding?
2 Does the mother’s special food supplement keep HIV-positive mothers healthy when they are breastfeeding?
3 Can HIV-positive mothers breastfeed for 6 months and stop while providing their babies a nutritious diet?
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